• Arylsulfatase A (ARSA) Mutation Analysis, Molecular Methods
  • Glomerular Basement Membrane Antibody, IgG
  • AIRE gene mutation
  • Entamoeba histolytica Antigen
  • Mu-opioid receptor 1 (OPRM1) Genotyping
  • Lamellar Body Count, Amniotic Fluid
  • Plasma Cell Assessment by Flow Cytometry, Blood
  • IKBKAP (Inhibitor of Kappa Light Polypeptide Gene Enhancer in B-cells, Kinase Complex-associated Protein) Gene Mutation Analysis
  • Chromosome Analysis, for Congenital Disorders, Blood
  • Anticholinergic poisoning
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Overview
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.